RM
Robbie Marcus JP Morgan Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
HTFL
1
Heartflow, Inc. Common Stock
HTFL
$2.83B
| $34.09 | $36 |
6%
upside
| Overweight | 2 days ago |
|
2
Cooper Companies
COO
$13.5B
| $68 | $66 |
3%
downside
| Neutral | 7 days ago |
|
3
Inspire Medical Systems
INSP
$2.55B
| $86.32 | $110 |
27%
upside
| Neutral | 1 month ago |
|
4
Edwards Lifesciences
EW
$47.5B
| $80.96 | $85 |
5%
upside
| Neutral | 1 month ago |
|
5
Neuropace
NPCE
$318M
| $9.61 | $16 |
66%
upside
| Overweight | 3 months ago |
|
6
Zimmer Biomet
ZBH
$20.8B
| $104.76 | $105 |
0%
upside
| Overweight | 4 months ago |
|
7
Integra LifeSciences
IART
$1.22B
| $15.65 | $12 |
23%
downside
| Underweight | 4 months ago |
|
8
CONMED
CNMD
$1.69B
| $54.69 | $58 |
6%
upside
| Neutral | 4 months ago |
|
9
RxSight
RXST
$347M
| $8.47 | $17 |
101%
upside
| Underweight | 5 months ago |
|
10
Merit Medical Systems
MMSI
$5.46B
| $92.15 | $120 |
30%
upside
| Overweight | 5 months ago |
|
11
Baxter International
BAX
$12.1B
| $23.58 | $36 |
53%
upside
| Neutral | 6 months ago |
|
12
Stryker
SYK
$151B
| $394.34 | $445 |
13%
upside
| Overweight | 7 months ago |
|
13
Intuitive Surgical
ISRG
$163B
| $454.52 | $675 |
49%
upside
| Overweight | 7 months ago |
|
14
Bioventus
BVS
$475M
| $7.10 | $13 |
83%
upside
| Neutral | 8 months ago |
|
15
Boston Scientific
BSX
$159B
| $107.29 | $110 |
3%
upside
| Overweight | 8 months ago |
|
16
Insulet
PODD
$24.4B
| $346.47 | $330 |
5%
downside
| Overweight | 8 months ago |
|
|
CBLL
17
CeriBell, Inc. Common Stock
CBLL
$452M
| $12.33 | $32 |
160%
upside
| Overweight | 10 months ago |
|
18
AtriCure
ATRC
$1.77B
| $35.66 | $40 |
12%
upside
| Overweight | 10 months ago |
|
19
DexCom
DXCM
$31.7B
| $80.76 | $85 |
5%
upside
| Neutral | 10 months ago |
|
20
GE HealthCare
GEHC
$33.8B
| $74.12 | $90 |
21%
upside
| Neutral | 1 year ago |
|
21
Enovis
ENOV
$1.8B
| $31.55 | $50 |
58%
upside
| Neutral | 1 year ago |
|
22
Treace Medical Concepts
TMCI
$453M
| $7.17 | $8 |
12%
upside
| Neutral | 1 year ago |
|
23
Penumbra
PEN
$10.9B
| $279.72 | $250 |
11%
downside
| Neutral | 1 year ago |
|
24
ZimVie
ZIMV
$533M
| $18.88 | $16 |
15%
downside
| Neutral | 1 year ago |
|
25
Bausch + Lomb
BLCO
$5.16B
| $14.59 | $17 |
17%
upside
| Neutral | 2 years ago |
|